These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 29785843

  • 1. Insulin therapy, weight gain and prognosis.
    Hodish I.
    Diabetes Obes Metab; 2018 Sep; 20(9):2085-2092. PubMed ID: 29785843
    [Abstract] [Full Text] [Related]

  • 2. Weight gain in type 2 diabetes mellitus.
    Jacob AN, Salinas K, Adams-Huet B, Raskin P.
    Diabetes Obes Metab; 2007 May; 9(3):386-93. PubMed ID: 17391167
    [Abstract] [Full Text] [Related]

  • 3. Contribution of change in glycosylated haemoglobin to insulin-associated weight gain: results of a longitudinal study in type 2 diabetic patients.
    Jansen HJ, Hendriks JC, de Galan BE, Penders G, Tack CJ, Vervoort G.
    Endocrine; 2011 Apr; 39(2):190-7. PubMed ID: 21069577
    [Abstract] [Full Text] [Related]

  • 4. Weight gain in insulin-treated patients by body mass index category at treatment initiation: new evidence from real-world data in patients with type 2 diabetes.
    Paul SK, Shaw JE, Montvida O, Klein K.
    Diabetes Obes Metab; 2016 Dec; 18(12):1244-1252. PubMed ID: 27502528
    [Abstract] [Full Text] [Related]

  • 5. Insulin glargine and educational intervention in patients with type 2 diabetes in clinical practice: long-term improvement in glycaemic control without weight gain.
    Schreiber SA, Russmann A.
    Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):41-2. PubMed ID: 16450317
    [No Abstract] [Full Text] [Related]

  • 6. For debate; pharmacological priorities in advanced type 2 diabetes.
    Hodish I.
    J Diabetes Complications; 2020 May; 34(5):107510. PubMed ID: 32008894
    [Abstract] [Full Text] [Related]

  • 7. Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c.
    Gallwitz B, Dagogo-Jack S, Thieu V, Garcia-Perez LE, Pavo I, Yu M, Robertson KE, Zhang N, Giorgino F.
    Diabetes Obes Metab; 2018 Feb; 20(2):409-418. PubMed ID: 28817231
    [Abstract] [Full Text] [Related]

  • 8. Insulin in type 2 diabetes: a useful alternative despite limited assessment based on surrogate endpoints.
    Prescrire Int; 2005 Oct; 14(79):187-93. PubMed ID: 16285076
    [Abstract] [Full Text] [Related]

  • 9. Beyond HbA1c.
    Bloomgarden Z.
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [Abstract] [Full Text] [Related]

  • 10. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
    Waugh N, Cummins E, Royle P, Clar C, Marien M, Richter B, Philip S.
    Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
    [Abstract] [Full Text] [Related]

  • 11. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS.
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [Abstract] [Full Text] [Related]

  • 12. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
    Vinagre I, Álvarez P, García N, Roura G, Conget I, en representación de los investigadores del estudio Comet.
    Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
    [Abstract] [Full Text] [Related]

  • 13. Diabetes-related distress, insulin dose, and age contribute to insulin-associated weight gain in patients with type 2 diabetes: results of a prospective study.
    Jansen HJ, Vervoort GM, de Haan AF, Netten PM, de Grauw WJ, Tack CJ.
    Diabetes Care; 2014 Oct; 37(10):2710-7. PubMed ID: 25011948
    [Abstract] [Full Text] [Related]

  • 14. Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE.
    Dornhorst A, Lüddeke HJ, Koenen C, Meriläinen M, King A, Robinson A, Sreenan S, PREDICTIVE Study Group.
    Diabetes Obes Metab; 2008 Jan; 10(1):75-81. PubMed ID: 18034846
    [Abstract] [Full Text] [Related]

  • 15. Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus.
    Mäkimattila S, Nikkilä K, Yki-Järvinen H.
    Diabetologia; 1999 Apr; 42(4):406-12. PubMed ID: 10230643
    [Abstract] [Full Text] [Related]

  • 16. Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetes.
    Bell DS, Ovalle F.
    Diabetes Obes Metab; 2006 Jan; 8(1):110-5. PubMed ID: 16367889
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of the addition of a dipeptidyl peptidase-4 inhibitor to insulin therapy in patients with type 2 diabetes: A systematic review and meta-analysis.
    Kim YG, Min SH, Hahn S, Oh TJ, Park KS, Cho YM.
    Diabetes Res Clin Pract; 2016 Jun; 116():86-95. PubMed ID: 27321321
    [Abstract] [Full Text] [Related]

  • 18. Glycaemic control without weight gain in insulin requiring type 2 diabetes: 1-year results of the GAME regimen.
    de Boer H, Keizers R, Jansen M, Verschoor L, Ruineman-Koerts J.
    Diabetes Obes Metab; 2006 Sep; 8(5):517-23. PubMed ID: 16918586
    [Abstract] [Full Text] [Related]

  • 19. [Optimised glycaemic control and dose titration with insulin glargine (Lantus) by general practitioners in Switzerland: results of the OPTI-LAN Postmarketing Study].
    Spirk D, Lareida J, Scheidegger K, Diem P.
    Praxis (Bern 1994); 2009 Mar 18; 98(6):315-20. PubMed ID: 19291638
    [Abstract] [Full Text] [Related]

  • 20. Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off study.
    Ridderstråle M, Evans LM, Jensen HH, Bøgelund M, Jensen MM, Ericsson Å, Jendle J.
    Health Qual Life Outcomes; 2016 Jan 22; 14():13. PubMed ID: 26801908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.